Diabetes Mellitus is a Multivariate Independent Prognostic Factor in Endometrial Carcinoma: a Clinicopathologic Study on 313 Patients
Overview
Oncology
Authors
Affiliations
Objective: The aim of this study was to analyse the influence of diabetes mellitus as a prognostic factor for overall survival in endometrial cancer.
Materials And Methods: Charts were reviewed from patients with endometrial carcinoma from 1985 to 2003. Data on clinicopathologic variables, adjuvant treatment, site of recurrence and survival were collected. The chi-square test was used to examine associations between variables. The Kaplan-Meier method was used for survival analysis and Cox's proportional hazards model for multiple regression analysis.
Results: Multivariate analysis revealed that diabetes mellitus, FIGO stage and depth of myometrial invasion were significantly associated with overall survival.
Hoos E, Koval L, Corcoran D, Eaves L, Roell K, Rager J Carcinogenesis. 2025; 46(1).
PMID: 39873457 PMC: 11894373. DOI: 10.1093/carcin/bgaf004.
McVicker L, Cardwell C, Edge L, McCluggage W, Quinn D, Wylie J BMC Cancer. 2022; 22(1):427.
PMID: 35439978 PMC: 9019948. DOI: 10.1186/s12885-022-09510-7.
Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
Guo H, Kong W, Zhang L, Han J, Clark L, Yin Y Am J Cancer Res. 2019; 9(10):2170-2193.
PMID: 31720081 PMC: 6834476.
Robertson M, Lyons E, Song J, Cox-Martin M, Li Y, Green C Health Qual Life Outcomes. 2019; 17(1):91.
PMID: 31133040 PMC: 6537149. DOI: 10.1186/s12955-019-1154-5.
Starling B, Kumar P, Lucas A, Barrow D, Farnan L, Hendrix L Cancer Chemother Pharmacol. 2018; 83(1):61-70.
PMID: 30327876 PMC: 6370499. DOI: 10.1007/s00280-018-3702-9.